Explore CyberKnife and ZAP-X technology at ERCM and learn how these advanced treatments can benefit patients. Read first-hand accounts from people who have received care at our centre, and discover more about our work through recent media coverage and press releases.
“It felt as though my whole world had collapsed,” Thorsten (57) recalls of the moment he learned that he had prostate cancer. Our patients speak openly about their individual journeys — from the initial diagnosis and the search for the most appropriate treatment option through to successful radiosurgical therapy.
Describing his CyberKnife treatment, he says: “You do not feel anything at all. The treatment is completely painless and takes only 30 minutes.” He adds: “I would like to express my sincere gratitude. You really feel exceptionally well cared for here.”
Below, you will find further authentic patient stories offering first-hand insight into the treatment experience and providing reassurance to others facing similar diagnoses.
A patient shares his impressive experience with CyberKnife treatment at the ERCM.
A patient shares his impressive experience with CyberKnife treatment for prostate cancer at the European Radiosurgery Center Munich (ERCM).
Mr. Meier reports on his experiences with the treatment of his uveal melanoma at the CyberKnife Center Munich.
Here, a Mobil Oil KK patient describes her experience of CyberKnife treatment of a benign but critically located brain tumor.
“Treating my prostate cancer with the CyberKnife method has preserved my quality of life.”
My brain is my personality! I therefore wanted a safe and effective treatment without the side effects that would have been possible with an operation.
In 2012, I was diagnosed with Gleason 7 prostate cancer and the doctors recommended “active observation”.
The CyberKnife radiation did not hurt at all and only one session was necessary, which was over after 25 minutes.
I tolerated the outpatient treatment of my vascular tumor in the brain very well and went straight home afterwards on the subway.
The CyberKnife treatment enabled me to resume my mountain biking and climbing hobbies in a very short time.
All the other doctors I went to refused to treat me.
Explore the latest press releases, interviews, articles and television reports about the European Radiosurgery Center Munich.
Coverage in leading publications, including DER SPIEGEL, Süddeutsche Zeitung, FOCUS and Münchner Merkur, offers insights into our work and the benefits of radiosurgery.
This video shows a uveal melanoma treatment in cooperation with the University Eye Clinic Munich.
In this episode, we discuss the possibilities of CyberKnife treatment for renal cell carcinoma together with our experts from the University of Munich's Großhadern Hospital.
In this video, the treatment options of CyberKnife radiosurgery for patients with acoustic neuroma are discussed together with our neurosurgical colleagues from the Großhadern Clin...
In this episode we talk about the possibilities of CyberKnife treatment for the therapy of spinal tumors.
Radiosurgery with the Cyberknife for tumors and metastases TALK with Dr. Erich Lejeune, Dr. Martin Marianowizc and Professor Alexander Muacevic.
Christoph Gogg from München TV talks to Prof. Dr. Alexander Muacevic and his team at the ERCM about modern CyberKnife therapies for prostate cancer.
Radiosurgery with the CyberKnife for tumors and metastases TALK with Dr. Erich Lejeune, Dr. Martin Marianowizc and Professor Alexander Muacevic.
Surgery, chemotherapy, radiotherapy - these are the three forms of therapy that most people associate with cancer treatment. They all raise many questions and fears.
Munich doctors treat cancer patients with the world's most modern radiosurgery robot.
With around 63,000 new cases per year, prostate cancer is the most common type of cancer and the third most common cause of death from malignant diseases in men in Germany.
Mit dem System betreiben wir Radiochirurgie, also eine Behandlung mit Strahlen, auf höchster Präzisionsstufe.
After a serious heart valve disease, Gerhard D. (54) received another shock diagnosis: a brain tumor.